Mexico vs Niger: Cause of death, by non-communicable diseases, ages 15-59, male
Mexico
40.0%
in 2021
Niger
39.6%
in 2021
Mexico rank
133rd
Niger rank
135th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Mexico
- Niger
How they compare
Mexico currently reports 40.0% against 39.6% in Niger, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Mexico ahead.
Mexico ranks 133rd and Niger ranks 135th of 185 countries.
Across the 3 decades both report, Mexico averaged higher in 2 and Niger in 1.
Head to head by decade
| Decade | Mexico | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 56.0% | 33.3% | 22.6% | Mexico |
| 2010s | 55.7% | 41.8% | 13.8% | Mexico |
| 2020s | 40.0% | 40.4% | 0.5% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Mexico or Niger?
- Mexico, at 40.0% against 39.6% in Niger as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Mexico and Niger?
- 0.4%, with Mexico ahead.
- How many years of comparable data are there for Mexico and Niger?
- 6 years are reported by both, from 2000 to 2021.
- How do Mexico and Niger rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Mexico ranks 133rd and Niger ranks 135th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.